Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 7,289,000 | 9,303,000 | 5,100,000 | 8,399,000 | 8,348,000 |
Marketable Securities | 772,000 | 486,000 | 1,323,000 | 8,000 | 26,000 |
Receivables | 5,384,000 | 5,088,000 | 4,758,000 | 4,730,000 | 3,735,000 |
Inventories | 1,605,000 | 1,605,000 | 1,444,000 | 1,719,000 | 1,124,000 |
Income taxes - deferred | N/A | N/A | N/A | N/A | 896,000 |
TOTAL | $16,945,000 | $21,223,000 | $16,187,000 | $16,314,000 | $16,081,000 |
Non-Current Assets | |||||
PPE Net | 2,883,000 | 2,803,000 | 2,604,000 | 2,565,000 | 2,485,000 |
Investments And Advances | 1,420,000 | 2,090,000 | 1,783,000 | 145,000 | 92,000 |
Intangibles | 36,896,000 | 43,344,000 | 44,313,000 | 32,877,000 | 7,375,000 |
Other Non-Current Assets | 1,208,000 | 1,326,000 | 1,212,000 | 1,149,000 | 1,480,000 |
TOTAL | $42,407,000 | $49,563,000 | $49,912,000 | $36,736,000 | $11,432,000 |
Total Assets | $59,352,000 | $70,786,000 | $66,099,000 | $53,050,000 | $27,513,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 5,308,000 | 6,415,000 | 402,000 | 2,431,000 | 4,439,000 |
Accounts payable and accrued liabilities | 11,931,000 | 10,226,000 | 9,379,000 | 8,463,000 | 6,954,000 |
TOTAL | $17,239,000 | $16,641,000 | $9,781,000 | $10,894,000 | $11,393,000 |
Non-Current Liabilities | |||||
Long Term Debt | 35,002,000 | 30,953,000 | 36,440,000 | 29,240,000 | 10,538,000 |
Other Non-Current Liabilities | 14,490,000 | 15,605,000 | 8,352,000 | 3,695,000 | 3,681,000 |
TOTAL | $50,559,000 | $49,048,000 | $51,682,000 | $38,211,000 | $14,378,000 |
Total Liabilities | $67,798,000 | $65,689,000 | $61,463,000 | $49,105,000 | $25,771,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 1,475,084 | 1,587,973 | 1,593,920 | 1,611,238 | 1,593,887 |
Common Shares | 18,000 | 18,000 | 18,000 | 17,000 | 16,000 |
Retained earnings | 3,368,000 | 5,459,000 | 4,378,000 | 2,248,000 | 535,000 |
Other shareholders' equity | -2,480,000 | -2,727,000 | -2,586,000 | -2,561,000 | -2,031,000 |
TOTAL | $-8,446,000 | $5,097,000 | $4,636,000 | $3,945,000 | $1,742,000 |
Total Liabilities And Equity | $59,352,000 | $70,786,000 | $66,099,000 | $53,050,000 | $27,513,000 |